TipRanks
Go Ultimate55% OFF

Core Laboratories (CLB) Capital Expenditure By Segment

Capital Expenditure By Segment

Details investment in each segment, reflecting strategic priorities and potential for future growth or efficiency improvements.

-$1.00M$0.00$1.00M$2.00M$3.00M$4.00M$5.00M$6.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

CapEx is concentrated in Reservoir Description and has become noticeably lumpy—recent quarterly spikes point to targeted lab/facility work and investments tied to new product deployments rather than a steady increase in baseline spending. Management’s FY‑26 capex guidance excludes an insurance‑covered U.K. rebuild, so visible spikes may reflect timing/insurance items that won’t raise the underlying run‑rate. With margins compressed and free cash flow weak, these episodic outlays matter: they support revenue-driving tech but constrain cash available for buybacks and debt reduction near term.

CLB Capital Expenditure By Segment

DateReservoir DescriptionProduction EnhancementCorporate & Other
Jun 30, 2026$4.63M$1.11M$35.00K
Mar 31, 2026$4.51M$306.00K$76.00K
Dec 31, 2025$3.30M$316.00K$39.00K
Sep 30, 2025$2.71M$183.00K$142.00K
Jun 30, 2025$3.75M$575.00K$0.00
Mar 31, 2025$2.42M$1.13M$28.00K
Dec 31, 2024$3.93M$404.00K$43.00K
Sep 30, 2024$2.27M$427.00K$29.00K
Jun 30, 2024$2.38M$267.00K$223.00K
Mar 31, 2024$2.83M$220.00K$2000.00
Dec 31, 2023$2.43M$570.00K-$268.00K
Sep 30, 2023$2.84M$237.00K$384.00K
Jun 30, 2023$1.48M$383.00K$315.00K
Mar 31, 2023$1.56M$618.00K$28.00K
Dec 31, 2022$1.74M$197.00K$86.00K
Sep 30, 2022$1.59M$1.10M$16.00K
Jun 30, 2022$2.05M$831.00K$315.00K
Mar 31, 2022$2.08M$57.00K$160.00K
Dec 31, 2021$2.79M$1.13M$833.00K
Sep 30, 2021$1.73M$637.00K$768.00K
Jun 30, 2021$2.65M$214.00K$17.00K
Mar 31, 2021$2.40M$304.00K$68.00K